Evidence map›Paper›PMID 24743304›Full record

ArticlePloS one2014

Soluble CEACAM8 interacts with CEACAM1 inhibiting TLR2-triggered immune responses.

Bernhard B Singer, Lena Opp, Annina Heinrich, Frauke Schreiber, Ramona Binding-Liermann, Luis Carlos Berrocal-Almanza, Kerstin A Heyl, Mario M Müller, Andreas Weimann, Janine Zweigner and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. The role of CEACAMs in neutrophil function.European journal of clinical investigation · 2024
    Review
  9. CEACAM1 in vascular homeostasis and inflammation.European journal of clinical investigation · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. CEACAM expression in anFrontiers in immunology · 2023
    Article
  14. Article
  15. Frontiers in cellular and infection microbiology · 2021
    Article
  16. Bioinformatics Analysis for Identifying Pertinent Pathways and Genes in Sepsis.Computational and mathematical methods in medicine · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bernhard B SingerInstitute of Anatomy, University Hospital, University Duisburg-Essen, Essen, Germany.
Lena OppInstitute of Microbiology and Hygiene, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Annina HeinrichInstitute of Microbiology and Hygiene, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Frauke SchreiberInstitute of Microbiology and Hygiene, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Ramona Binding-LiermannInstitute of Microbiology and Hygiene, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Luis Carlos Berrocal-AlmanzaInstitute of Microbiology and Hygiene, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Kerstin A HeylZIK Septomics, University Hospital Jena, Jena, Germany.
Mario M MüllerZIK Septomics, University Hospital Jena, Jena, Germany.
Andreas WeimannLabor Berlin - Charité Vivantes Services GmbH, Berlin, Germany; Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry of the Charité Universitätsmedizin Berlin, Berlin, Germany.
Janine ZweignerInstitute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Hortense SlevogtZIK Septomics, University Hospital Jena, Jena, Germany.
Charité - Universitätsmedizin Berlin · DEJena University Hospital · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lower respiratory tract bacterial infections are characterized by neutrophilic inflammation in the airways. The carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 8 is expressed in and released by human granulocytes. Our study demonstrates that human granulocytes release CEACAM8 in response to bacterial DNA in a TLR9-dependent manner. Individuals with a high percentage of bronchial lavage fluid (BALF) granulocytes were more likely to have detectable levels of released CEACAM8 in the BALF than those with a normal granulocyte count. Soluble, recombinant CEACAM8-Fc binds to CEACAM1 expressed on human airway epithelium. Application of CEACAM8-Fc to CEACAM1-positive human pulmonary epithelial cells resulted in reduced TLR2-dependent inflammatory responses. These inhibitory effects were accompanied by tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM) of CEACAM1 and by recruitment of the phosphatase SHP-1, which could negatively regulate Toll-like receptor 2-dependent activation of the phosphatidylinositol 3-OH kinase-Akt kinase pathway. Our results suggest a new mechanism by which granulocytes reduce pro-inflammatory immune responses in human airways via secretion of CEACAM8 in neutrophil-driven bacterial infections.

Indexed as

AnimalsAntigens, CDBronchiBronchoalveolar Lavage FluidCell Adhesion MoleculesCell CountCell LineCytochalasin DEpithelial CellsGPI-Linked ProteinsGranulocytesHumansProtein BindingRatsSignal TransductionSolubilityAntigens, CDCD66 antigensCEACAM8 protein, humanCell Adhesion MoleculesCytochalasin DGPI-Linked ProteinsTLR2 protein, humanToll-Like Receptor 2Toll-Like Receptor 9

Identifiers

PMID24743304
PMCPMC3990526
OpenAlexW1972979687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.